EUVIMEDEUVIMED entdecken
Crossref

Whole-brain metabolic activity on pretreatment [18 F]FDG PET/CT provides prognostic information beyond metabolic tumour burden in patients with breast cancer

Mehmet Tarık Tatoğlu, Burak Canıtez, Hatice Uslu, Ebru İbişoğlu, Ferda Yerdelen Tatoğlu

European Journal of Nuclear Medicine and Molecular Imaging · 2026

DOI: 10.1007/s00259-026-08046-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Mehmet Tarık Tatoğlu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Kadikoy, Istanbul, Türkiye. tariktatoglu@gmail.com. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Breast Neoplasms, Tumor Burden. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyFluorodeoxyglucose F18Breast NeoplasmsTumor BurdenBrainHumansFemalePrognosisRetrospective StudiesMiddle AgedAgedAdultRadiopharmaceuticals

Stichwörter der Autor:innen

Breast cancerMetabolic tumour burdenOverall survivalWhole-brain FDG uptake[18F]FDG PET/CT

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Kadikoy, Istanbul, Türkiye. tariktatoglu@gmail.com.
  • Department of Nuclear Medicine, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Kadikoy, Istanbul, Türkiye.
  • Faculty of Medicine, Istanbul Medeniyet University, Uskudar, Istanbul, Türkiye.
  • Department of Econometrics, Faculty of Economics, Istanbul University, Fatih, Istanbul, Türkiye.

Zitieren

APA

Tatoğlu, M. T., Canıtez, B., Uslu, H., İbişoğlu, E., & Tatoğlu, F. Y. (2026). Whole-brain metabolic activity on pretreatment [18 F]FDG PET/CT provides prognostic information beyond metabolic tumour burden in patients with breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-026-08046-3

Vancouver

Tatoğlu MT, Canıtez B, Uslu H, İbişoğlu E, Tatoğlu FY. Whole-brain metabolic activity on pretreatment [18 F]FDG PET/CT provides prognostic information beyond metabolic tumour burden in patients with breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-026-08046-3

BibTeX
@article{Tatolu2026,
  author = {Tatoğlu, Mehmet Tarık and Canıtez, Burak and Uslu, Hatice and İbişoğlu, Ebru and Tatoğlu, Ferda Yerdelen},
  title = {Whole-brain metabolic activity on pretreatment [18 F]FDG PET/CT provides prognostic information beyond metabolic tumour burden in patients with breast cancer},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  doi = {10.1007/s00259-026-08046-3}
}
Kostenlos starten →